1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. United States >
  6. Pennsylvania >
  7. Cephalon >
  8. M&A

Cephalon Mergers & Acquisitions

Cephalon M&A Summary

Cephalon has acquired 8 companies of its own. A total of 5 acquisitions came from private equity firms.

Cephalon’s largest acquisition to date was in 2010, when it acquired Mepha Pharma Ag for $615M. Cephalon has acquired in 3 different US states, and 4 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity7
    • M&A Buy Activity7
  • Total Sectors Invested 1
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 5

Cephalon, Inc.

41 Moores Road,
Frazer, Pennsylvania 19355
United States,
(610) 344-0200
www.cephalon.com

All (7) Buy (7) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2011-03-28 ChemGenex Pharmaceuticals, Inc. · Life Science
Menlo Park, California · www.chemgenex.com

ChemGenex Pharmaceuticals is a pharmaceutical development company dedicated to improving the lives of patients by developing personalized therapeutics in the areas of oncology, diabetes and obesity. ChemGenex’s lead compound, Ceflatonin®, is currently in Phase 2/3 clinical trials for chronic myeloid leukemia and Quinamed® is in Phase 2 clinical trials for several solid cancers. ChemGenex's pipeline also includes several pre-clinical stage anti-diabetes lead mole.

231 Add-on Acquisition

Cephalon, Inc.

Alta Partners PE

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal